Citizens Maintains Stryker Outperform, Cuts Price Target to $390
Citizens maintained its Market Outperform rating on Stryker and lowered its price target to $390 from $400.
Citizens maintained its Market Outperform rating on Stryker and lowered its price target to $390 from $400.